<![CDATA[EU/3/16/1731 (Synthetic double-stranded siRNA oligonucleotide directed against delta-aminolevulinic acid synthase 1 mRNA covalently linked to a ligand containing three N-acetylgalactosamine residues)

<![CDATA[EU/3/16/1731 (Synthetic double-stranded siRNA oligonucleotide directed against delta-aminolevulinic acid synthase 1 mRNA covalently linked to a ligand containing three N-acetylgalactosamine residues) - Alnylam UK Limited]]> 1440 Copyright: (C) European Commission en-gb Wed, 31 Aug 2016 12:08:00 +0000 http://ec.europa.eu/health/documents/community-register/html/o1731.htm <![CDATA[EU/3/16/1731 (Synthetic double-stranded siRNA oligonucleotide directed against delta-aminolevulinic acid synthase 1 mRNA covalently linked to a ligand containing three N-acetylgalactosamine residues) - Alnylam UK Limited]]> http://ec.europa.eu/health/documents/community-register/images/logo_en.gif http://ec.europa.eu/health/documents/community-register/html/o1731.htm 144 100 Orphan designation - Commission Decision (2016)5638 of Wed, 31 Aug 2016 New documents http://ec.europa.eu/health/documents/community-register/html/o1731.htm#proc135781 http://ec.europa.eu/health/documents/community-register/html/o1731.htm#proc135781 Wed, 31 Aug 2016 12:08:00 +0000